Mycoplasma pneumoniae infection, antibiotics and exanthema

Infection
|January 1, 1980
PubMed

Insights

Most patients with Mycoplasma pneumoniae infection received multiple antibiotics, often penicillins. Antibiotic-induced skin rashes were common, suggesting they are not reliable indicators of this pneumonia.

Area of Science:

  • Infectious Diseases
  • Dermatology
  • Pharmacology

Background:

  • Mycoplasma pneumoniae is a common cause of respiratory infections.
  • Antibiotic use is standard for bacterial infections, but Mycoplasma pneumoniae treatment can be complex.
  • Skin manifestations in infections can be diagnostic or treatment-related.

Purpose of the Study:

  • To investigate antibiotic prescribing patterns in Mycoplasma pneumoniae infections.
  • To determine the incidence and characteristics of skin rashes in these patients.
  • To assess the potential link between antibiotic use and observed rashes.

Main Methods:

  • Retrospective survey of 81 patients with confirmed Mycoplasma pneumoniae infection.
  • Analysis of patient records for antibiotic treatments and observed symptoms, specifically skin rashes.
  • Categorization of rash types and correlation with antibiotic administration.

Main Results:

  • 72% of patients received two or more antibiotics, with ampicillin and penicillins frequently used.
  • 18.5% of patients developed skin rashes, predominantly erythematous maculopapular.
  • The study suggests these rashes are likely antibiotic-induced.

Conclusions:

  • Extensive antibiotic use, including penicillins, is common in Mycoplasma pneumoniae infections.
  • Erythematous maculopapular rashes in these patients are probably a side effect of antibiotics.
  • Such rashes are unlikely to be a specific indicator of Mycoplasma pneumoniae pneumonia, unlike other rash types.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...